HacA-Independent Functions of the ER Stress Sensor IreA Synergize with the Canonical UPR to Influence Virulence Traits in Aspergillus fumigatus X Feng, K Krishnan, DL Richie, V Aimanianda, L Hartl, N Grahl, ... PLoS pathogens 7 (10), e1002330, 2011 | 117 | 2011 |
Effect of ivermectin vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial S Naggie, DR Boulware, CJ Lindsell, TG Stewart, N Gentile, S Collins, ... Jama 328 (16), 1595-1603, 2022 | 73 | 2022 |
Updates in laboratory diagnostics for invasive fungal infections D Terrero-Salcedo, MV Powers-Fletcher Journal of Clinical Microbiology 58 (6), 10.1128/jcm. 01487-19, 2020 | 55 | 2020 |
Effect of higher-dose ivermectin for 6 days vs placebo on time to sustained recovery in outpatients with COVID-19: a randomized clinical trial S Naggie, DR Boulware, CJ Lindsell, TG Stewart, AJ Slandzicki, SC Lim, ... JAMA 329 (11), 888-897, 2023 | 50 | 2023 |
Effect of fluvoxamine vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial MW McCarthy, S Naggie, DR Boulware, CJ Lindsell, TG Stewart, ... JAMA 329 (4), 296-305, 2023 | 48 | 2023 |
Filamentous fungi MV Powers-Fletcher, BA Kendall, AT Griffin, KE Hanson Diagnostic Microbiology of the Immunocompromised Host, 311-341, 2016 | 48 | 2016 |
The virulence of the opportunistic fungal pathogen Aspergillus fumigatus requires cooperation between the endoplasmic reticulum-associated degradation … DL Richie, X Feng, L Hartl, V Aimanianda, K Krishnan, ... Virulence 2 (1), 12-21, 2011 | 47 | 2011 |
Cost-effectiveness analysis of multiplex PCR with magnetic resonance detection versus empiric or blood culture-directed therapy for management of suspected candidemia B Walker, MV Powers-Fletcher, RL Schmidt, KE Hanson Journal of clinical microbiology 54 (3), 718-726, 2016 | 37 | 2016 |
Nonculture diagnostics in fungal disease MV Powers-Fletcher, KE Hanson Infectious Disease Clinics 30 (1), 37-49, 2016 | 33 | 2016 |
Molecular diagnostic testing for Aspergillus MV Powers-Fletcher, KE Hanson Journal of clinical microbiology 54 (11), 2655-2660, 2016 | 30 | 2016 |
Effects of a defective endoplasmic reticulum-associated degradation pathway on the stress response, virulence, and antifungal drug susceptibility of the mold pathogen … K Krishnan, X Feng, MV Powers-Fletcher, G Bick, DL Richie, LA Woollett, ... Eukaryotic cell 12 (4), 512-519, 2013 | 29 | 2013 |
Deletion of the sec4 Homolog srgA from Aspergillus fumigatus Is Associated with an Impaired Stress Response, Attenuated Virulence and Phenotypic Heterogeneity MV Powers-Fletcher, X Feng, K Krishnan, DS Askew PloS one 8 (6), e66741, 2013 | 22 | 2013 |
Impact of the Lectin Chaperone Calnexin on the Stress Response, Virulence and Proteolytic Secretome of the Fungal Pathogen Aspergillus fumigatus MV Powers-Fletcher, K Jambunathan, JL Brewer, K Krishnan, X Feng, ... PLoS One 6 (12), e28865, 2011 | 17 | 2011 |
The virulence of the opportunistic fungal pathogen Aspergillus fumigatus requires cooperation between the endoplasmic reticulum-associated degradation pathway (ERAD) and the … DL Richie, X Feng, L Hartl, V Aimanianda, K Krishnan, ... Epub 2011/01/11. https://doi. org/10.4161/viru. 2.1. 13345 PMID: 21217201, 2011 | 15 | 2011 |
Higher-dose fluvoxamine and time to sustained recovery in outpatients with COVID-19: the ACTIV-6 randomized clinical trial TG Stewart, PA Rebolledo, A Mourad, CJ Lindsell, DR Boulware, ... JAMA 330 (24), 2354-2363, 2023 | 13 | 2023 |
Diagnosing fracture-related infections: where are we now? MC Stevenson, JC Slater, HC Sagi, F Palacio Bedoya, ... Journal of clinical microbiology 60 (2), e02807-20, 2022 | 13 | 2022 |
Clinical and demographic factors associated with COVID-19, severe COVID-19, and SARS-CoV-2 infection in adults: a secondary cross-protocol analysis of 4 randomized clinical trials DA Theodore, AR Branche, L Zhang, DS Graciaa, M Choudhary, ... JAMA network open 6 (7), e2323349-e2323349, 2023 | 11 | 2023 |
Non-Helicobacter pylori Helicobacter species associated with human disease: a primer for the clinical microbiology laboratory MV Powers-Fletcher, MR Couturier Clinical Microbiology Newsletter 37 (12), 93-101, 2015 | 9 | 2015 |
Risk of COVID-19 after natural infection or vaccination AM Rick, MB Laurens, Y Huang, C Yu, TCS Martin, CA Rodriguez, ... EBioMedicine 96, 2023 | 6 | 2023 |
Immune and ionic mechanisms mediating the effect of dexamethasone in severe COVID-19 AA Chimote, AO Alshwimi, M Chirra, VS Gawali, MV Powers-Fletcher, ... Frontiers in Immunology 14, 1143350, 2023 | 6 | 2023 |